We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Filtering Donor Blood Reduces Complications in the Recipient

By LabMedica International staff writers
Posted on 06 Jul 2010
When foreign white cells were filtered from donor blood, there were dramatically fewer cardiopulmonary complications in recipients.

An observational study was conducted during the seven years before and after 2000, when the University of Rochester Medical Center (URMC; Rochester, NY, USA) introduced universal leukoreduction, a process that filters the white cells from blood to be used for transfusions. More...
Investigators looked at the number of reports of transfusion reactions during the 14-year period, and divided them by the total number of blood components transfused (778, 559).

Rates of acute, transfusion-related lung injury dropped 83 % in the years after filtering took place, and transfusion-associated circulatory overload declined 49 %, when compared to the rates prior to the year 2000. Both conditions are rare, but are among the most common causes of death following a transfusion.

"These data are very exciting because we described two unexpected and unexplained associations between adverse reactions and leukoreduction," said Neil Blumberg, M.D. who led the study. "However, our observations do not prove cause and effect, and therefore require further investigation before we can say with certainty that leukoreduction is responsible for so many fewer cardiopulmonary complications."

The [U.S.] Centers for Disease Control and Prevention (Atlanta, GA, USA) is introducing a new blood surveillance system to track severe transfusion reactions, which should provide more detailed information to support or refute the URMC study.

The study appears in the June 18, 2010, online edition of the journal Transfusion.

Work done at URMC also has supported keeping transfusions to an absolute minimum. Dr. Blumberg's evidence-based stance on the judicious use of transfusions and safer techniques has contributed greatly to the national and international dialogue on reducing in-hospital infections rates and controlling costs.

Related Links:
University of Rochester Medical Center
U.S. Centers for Disease Control and Prevention




New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Multi-Chamber Washer-Disinfector
WD 390
New
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.